Eliem Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Eliem Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Eliem Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eliem Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $65k | 13k | 5.09 |
| 2024-06-30 | $22k | 3.1k | 7.11 |
| 2023-12-31 | $3 | 1 | 3.00 |
| 2022-03-31 | $24k | 2.8k | 8.48 |
| 2021-12-31 | $2.2M | 208k | 10.46 |